These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 28387458)
1. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells. Wright C; Iyer AKV; Kaushik V; Azad N J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458 [TBL] [Abstract][Full Text] [Related]
2. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
3. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462 [TBL] [Abstract][Full Text] [Related]
4. AICAR induces AMPK-independent programmed necrosis in prostate cancer cells. Guo F; Liu SQ; Gao XH; Zhang LY Biochem Biophys Res Commun; 2016 May; 474(2):277-283. PubMed ID: 27103440 [TBL] [Abstract][Full Text] [Related]
5. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase. Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081 [TBL] [Abstract][Full Text] [Related]
6. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway. Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073 [TBL] [Abstract][Full Text] [Related]
8. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells. Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338 [TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer. Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507 [TBL] [Abstract][Full Text] [Related]
10. The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer. Sadowski MC; Pouwer RH; Gunter JH; Lubik AA; Quinn RJ; Nelson CC Oncotarget; 2014 Oct; 5(19):9362-81. PubMed ID: 25313139 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Zhuge J Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182 [TBL] [Abstract][Full Text] [Related]
12. AICAR activates ER stress-dependent apoptosis in gallbladder cancer cells. Nie J; Liu A; Tan Q; Zhao K; Hu K; Li Y; Yan B; Zhou L Biochem Biophys Res Commun; 2017 Jan; 482(2):246-252. PubMed ID: 27847321 [TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Jia F; Wu C; Chen Z; Lu G Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964 [TBL] [Abstract][Full Text] [Related]
14. Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis. Theodoropoulou S; Brodowska K; Kayama M; Morizane Y; Miller JW; Gragoudas ES; Vavvas DG PLoS One; 2013; 8(1):e52852. PubMed ID: 23300996 [TBL] [Abstract][Full Text] [Related]
15. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines. Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391 [TBL] [Abstract][Full Text] [Related]
16. LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR. Russe OQ; Möser CV; Kynast KL; King TS; Olbrich K; Grösch S; Geisslinger G; Niederberger E Biochem Biophys Res Commun; 2014 May; 447(3):520-5. PubMed ID: 24732361 [TBL] [Abstract][Full Text] [Related]
17. Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines. Hill TK; Davis AL; Wheeler FB; Kelkar SS; Freund EC; Lowther WT; Kridel SJ; Mohs AM Mol Pharm; 2016 Mar; 13(3):720-8. PubMed ID: 26824142 [TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules. Kant S; Kumar A; Singh SM Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747 [TBL] [Abstract][Full Text] [Related]
19. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside. Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner. Roberto D; Klotz LH; Venkateswaran V Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]